Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 17482134)


Rewired ERK-JNK signaling pathways in melanoma.

Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S, Ronai Z.

Cancer Cell. 2007 May;11(5):447-60.


c-Jun regulates phosphoinositide-dependent kinase 1 transcription: implication for Akt and protein kinase C activities and melanoma tumorigenesis.

Lopez-Bergami P, Kim H, Dewing A, Goydos J, Aaronson S, Ronai Z.

J Biol Chem. 2010 Jan 8;285(2):903-13. doi: 10.1074/jbc.M109.075630. Epub 2009 Nov 12.


c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.

Sprowles A, Robinson D, Wu YM, Kung HJ, Wisdom R.

Exp Cell Res. 2005 Aug 15;308(2):459-68.


Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma.

Kunz M, Ibrahim S, Koczan D, Thiesen HJ, Köhler HJ, Acker T, Plate KH, Ludwig S, Rapp UR, Bröcker EB, van Muijen GN, Flory E, Gross G.

Cell Growth Differ. 2001 Mar;12(3):137-45.


Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells.

Lee CC, Chen SC, Tsai SC, Wang BW, Liu YC, Lee HM, Shyu KG.

J Biomed Sci. 2006 Jan;13(1):143-56. Epub 2005 Nov 22.


Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors.

Shen YH, Godlewski J, Zhu J, Sathyanarayana P, Leaner V, Birrer MJ, Rana A, Tzivion G.

J Biol Chem. 2003 Jul 18;278(29):26715-21. Epub 2003 May 8.


Regionally selective activation and differential regulation of ERK, JNK and p38 MAP kinase signalling pathway by protein kinase C in mood modulation.

Galeotti N, Ghelardini C.

Int J Neuropsychopharmacol. 2012 Jul;15(6):781-93. doi: 10.1017/S1461145711000897. Epub 2011 Jun 20.


Ultraviolet-induced junD activation and apoptosis in myeloblastic leukemia ML-1 cells.

Li T, Dai W, Lu L.

J Biol Chem. 2002 Sep 6;277(36):32668-76. Epub 2002 Jun 24.


Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions.

Shen CP, Tsimberg Y, Salvadore C, Meller E.

BMC Neurosci. 2004 Sep 20;5:36.


The protein kinase C inhibitor, Ro-31-7459, is a potent activator of ERK and JNK MAP kinases in HUVECs and yet inhibits cyclic AMP-stimulated SOCS-3 gene induction through inactivation of the transcription factor c-Jun.

Wiejak J, Dunlop J, Stoyle C, Lappin G, McIlroy A, Pediani JD, Gao S, Yarwood SJ.

Cell Signal. 2012 Aug;24(8):1690-9. doi: 10.1016/j.cellsig.2012.04.016. Epub 2012 Apr 25.


Regulation of docetaxel-induced apoptosis of human melanoma cells by different isoforms of protein kinase C.

Mhaidat NM, Thorne RF, Zhang XD, Hersey P.

Mol Cancer Res. 2007 Oct;5(10):1073-81.


Downregulation of cyclin D1-CDK4 protein in human embryonic lung fibroblasts (HELF) induced by silica is mediated through the ERK and JNK pathway.

Shen F, Fan X, Liu B, Jia X, Gao A, Du H, Ye M, You B, Huang C, Shi X.

Cell Biol Int. 2008 Oct;32(10):1284-92. doi: 10.1016/j.cellbi.2008.07.015. Epub 2008 Jul 25.


Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling.

Bhatt KV, Spofford LS, Aram G, McMullen M, Pumiglia K, Aplin AE.

Oncogene. 2005 May 12;24(21):3459-71.


Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.

Ambrosini G, Pratilas CA, Qin LX, Tadi M, Surriga O, Carvajal RD, Schwartz GK.

Clin Cancer Res. 2012 Jul 1;18(13):3552-61. doi: 10.1158/1078-0432.CCR-11-3086. Epub 2012 May 1.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk